CFTR negatively regulates cyclooxygenase-2-PGE 2 positive feedback loop in inflammation

Journal of Cellular Physiology

Volumn 227, Issue 6, 2012, Pages 2759-2766

  Chen, Jing ^a   Jiang, Xiao Hua ^a   Chen, Hui ^a   Guo, Jing Hui ^a   Tsang, Lai Ling ^a   Yu, Mei Kuen ^a   Xu, Wen Ming ^b   Chan, Hsiao Chang ^a,b  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHUS MUCOSA; CONTROLLED STUDY; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MOUSE; HUMAN; HUMAN CELL; INFLAMMATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; WILD TYPE;

ANIMALS; CELL LINE; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLOOXYGENASE 2; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DINOPROSTONE; DISEASE MODELS, ANIMAL; FEEDBACK, PHYSIOLOGICAL; HUMANS; MICE; MICE, INBRED CFTR; NF-KAPPA B; PNEUMONIA; PSEUDOMONAS AERUGINOSA; RESPIRATORY MUCOSA; RESPIRATORY TRACT INFECTIONS; TIME FACTORS; TRANSFECTION;

MUS;

EID: 84863115682     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.23020     Document Type: Article

References (54)

1. Andersson C, Zaman MM, Jones AB, Freedman SD. 2008. Alterations in immune response and PPAR/LXR regulation in cystic fibrosis macrophages. J Cyst Fibros 7:68-78.
2. Aronoff DM, Canetti C, Peters-Golden M. 2004. Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP. J Immunol 173:559-565.
3. Baudouin-Legros M, Hamdaoui N, Borot F, Fritsch J, Ollero M, Planelles G, Edelman A. 2008. Control of basal CFTR gene expression by bicarbonate-sensitive adenylyl cyclase in human pulmonary cells. Cell Physiol Biochem 21:75-86.
4. Bennett A, Charlier EM, McDonald AM, Simpson JS, Stamford IF, Zebro T. 1977. Prostaglandins and breast cancer. Lancet 2:624-626.
5. Bonfield TL, Panuska JR, Konstan MW, Hilliard KA, Hilliard JB, Ghnaim H, Berger M. 1995. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 152:2111-2118.
6. Bonfield TL, Konstan MW, Berger M. 1999. Altered respiratory epithelial cell cytokine production in cystic fibrosis. J Allergy Clin Immunol 104:72-78.
7. Breder CD, Saper CB. 1996. Expression of inducible cyclooxygenase mRNA in the mouse brain after systemic administration of bacterial lipopolysaccharide. Brain Res 713:64-69.
8. Caristi S, Piraino G, Cucinotta M, Valenti A, Loddo S, Teti D. 2005. Prostaglandin E2 induces interleukin-8 gene transcription by activating C/EBP homologous protein in human T lymphocytes. J Biol Chem 280:14433-14442.
9. Chen CN, Hsieh FJ, Cheng YM, Chang KJ, Lee PH. 2006. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer. J Surg Oncol 94:226-233.
10. Clayton AJ. 1996. Possible origins, transmission patterns, and future course of AIDS. J Travel Med 3:231-234.
11. Collins FS. 1992. Cystic fibrosis: Molecular biology and therapeutic implications. Science 256:774-779.
12. Corvol H, Fitting C, Chadelat K, Jacquot J, Tabary O, Boule M, Cavaillon JM, Clement A. 2003. Distinct cytokine production by lung and blood neutrophils from children with cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 284:L997-L1003.
13. Czerska K, Sobczynska-Tomaszewska A, Sands D, Nowakowska A, Bak D, Wertheim K, Poznanski J, Zielenski J, Norek A, Bal J. 2010. Prostaglandin-endoperoxide synthase genes COX1 and C. J Appl Genet 51:323-330.
14. Dakin CJ, Numa AH, Wang H, Morton JR, Vertzyas CC, Henry RL. 2002. Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 165:904-910.
15. Davis PB, Drumm M, Konstan MW. 1996. Cystic fibrosis. Am J Respir Crit Care Med 154:1229-1256.
16. Dechecchi MC, Nicolis E, Bezzerri V, Vella A, Colombatti M, Assael BM, Mettey Y, Borgatti M, Mancini I, Gambari R, Becq F, Cabrini G. 2007. MPB-07 reduces the inflammatory response to Pseudomonas aeruginosa in cystic fibrosis bronchial cells. Am J Respir Cell Mol Biol 36:615-624.
17. DiMango E, Ratner AJ, Bryan R, Tabibi S, Prince A. 1998. Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J Clin Invest 101:2598-2605.
18. Ehrhardt C, Collnot EM, Baldes C, Becker U, Laue M, Kim KJ, Lehr CM. 2006. Towards an in vitro model of cystic fibrosis small airway epithelium: Characterisation of the human bronchial epithelial cell line CFBE41o- Cell Tissue Res 323:405-415.
19. Estell K, Braunstein G, Tucker T, Varga K, Collawn JF, Schwiebert LM. 2003. Plasma membrane CFTR regulates RANTES expression via its C-terminal PDZ-interacting motif. Mol Cell Biol 23:594-606.
20. Faour WH, Gomi K, Kennedy CR. 2008. PGE(2) induces COX-2 expression in podocytes via the EP(4) receptor through a PKA-independent mechanism. Cell Signal 20:2156-2164.
21. Heeckeren A, Walenga R, Konstan MW, Bonfield T, Davis PB, Ferkol T. 1997. Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa. J Clin Invest 100:2810-2815.
22. Hinz B, Brune K, Pahl A. 2000. Cyclooxygenase-2 expression in lipopolysaccharide-stimulated human monocytes is modulated by cyclic AMP, prostaglandin E(2), and nonsteroidal anti-inflammatory drugs. Biochem Biophys Res Commun 278:790-796.
23. Hunter MJ, Treharne KJ, Winter AK, Cassidy DM, Land S, Mehta A. 2010. Expression of wild-type CFTR suppresses NF-kappaB-driven inflammatory signalling. PLoS ONE 5:e11598.
24. Kemp JP. 2003. Recent advances in the management of asthma using leukotriene modifiers. Am J Respir Med 2:139-156.
25. Konstan MW. 2008. Ibuprofen therapy for cystic fibrosis lung disease: Revisited. Curr Opin Pulm Med 14:567-573.
26. Konstan MW, Walenga RW, Hilliard KA, Hilliard JB. 1993. Leukotriene B4 markedly elevated in the epithelial lining fluid of patients with cystic fibrosis 1. Am Rev Respir Dis 148:896-901.
27. Konstan MW, Byard PJ, Hoppel CL, Davis PB. 1995. Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med 332:848-854.
28. Korhonen R, Kosonen O, Korpela R, Moilanen E. 2004. The expression of COX2 protein induced by Lactobacillus rhamnosus GG, endotoxin and lipoteichoic acid in T84 epithelial cells. Lett Appl Microbiol 39:19-24.
29. Liu Y, Jiang X, Yu MK, Dong J, Zhang X, Tsang LL, Chung YW, Li T, Chan HC. 2010. Switching from bone marrow-derived neurons to epithelial cells through dedifferentiation and translineage redifferentiation. Cell Biol Int 34:1075-1083.
30. Machen TE. 2006. Innate immune response in CF airway epithelia: Hyperinflammatory? Am J Physiol Cell Physiol 291:C218-C230.
31. Maier JA, Hla T, Maciag T. 1990. Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells. J Biol Chem 265:10805-10808.
32. Mitchell JA, Belvisi MG, Akarasereenont P, Robbins RA, Kwon OJ, Croxtall J, Barnes PJ, Vane JR. 1994. Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: Regulation by dexamethasone. Br J Pharmacol 113:1008-1014.
33. Muhlebach MS, Noah TL. 2002. Endotoxin activity and inflammatory markers in the airways of young patients with cystic fibrosis. Am J Respir Crit Care Med 165:911-915.
34. Muhlebach MS, Stewart PW, Leigh MW, Noah TL. 1999. Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. Am J Respir Crit Care Med 160:186-191.
35. Prescott SM. 2000. Is cyclooxygenase-2 the alpha and the omega in cancer? J Clin Invest 105:1511-1513.
36. Resta-Lenert S, Barrett KE. 2002. Enteroinvasive bacteria alter barrier and transport properties of human intestinal epithelium: Role of iNOS and COX-2. Gastroenterology 122:1070-1087.
37. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL. 1989. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 245:1066-1073.
38. Roca-Ferrer J, Pujols L, Gartner S, Moreno A, Pumarola F, Mullol J, Cobos N, Picado C. 2006. Upregulation of COX-1 and COX-2 in nasal polyps in cystic fibrosis. Thorax 61:592-596.
39. Rodgers HC, Pang L, Holland E, Corbett L, Range S, Knox AJ. 2002. Bradykinin increases IL-8 generation in airway epithelial cells via COX-2-derived prostanoids. Am J Physiol Lung Cell Mol Physiol 283:L612-L618.
40. Saadane A, Soltys J, Berger M. 2006. Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kappa B activation, cytokine secretion, and persistent lung inflammation. J Allergy Clin Immunol 117:1163-1169.
41. Schwiebert LM, Estell K, Propst SM. 1999. Chemokine expression in CF epithelia: Implications for the role of CFTR in RANTES expression. Am J Physiol 276:C700-C710.
42. Sheppard DN, Carson MR, Ostedgaard LS, Denning GM, Welsh MJ. 1994. Expression of cystic fibrosis transmembrane conductance regulator in a model epithelium. Am J Physiol 266:L405-L413.
43. Smith JJ, Travis SM, Greenberg EP, Welsh MJ. 1996. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85:229-236.
44. Smith WL, DeWitt DL, Garavito RM. 2000. Cyclooxygenases: Structural, cellular, and molecular biology. Annu Rev Biochem 69:145-182.
45. Snouwaert JN, Brigman KK, Latour AM, Malouf NN, Boucher RC, Smithies O, Koller BH. 1992. An animal model for cystic fibrosis made by gene targeting. Science 257:1083-1088.
46. Strandvik B, Svensson E, Seyberth HW. 1996. Prostanoid biosynthesis in patients with cystic fibrosis. Prostaglandins Leukot Essent Fatty Acids 55:419-425.
47. Tavakoli S, Cowan MJ, Benfield T, Logun C, Shelhamer JH. 2001. Prostaglandin E(2)-induced interleukin-6 release by a human airway epithelial cell line. Am J Physiol Lung Cell Mol Physiol 280:L127-L133.
48. Tirouvanziam R, de Bentzmann S, Hubeau C, Hinnrasky J, Jacquot J, Peault B, Puchelle E. 2000. Inflammation and infection in naive human cystic fibrosis airway grafts. Am J Respir Cell Mol Biol 23:121-127.
49. Verhaeghe C, Delbecque K, de LL, Oury C, Bours V. 2007. Early inflammation in the airways of a cystic fibrosis foetus. J Cyst Fibros 6:304-308.
50. Vij N, Mazur S, Zeitlin PL. 2009. CFTR is a negative regulator of NFkappaB mediated innate immune response. PLoS ONE 4:e4664.
51. Weber AJ, Soong G, Bryan R, Saba S, Prince A. 2001. Activation of NF-kappaB in airway epithelial cells is dependent on CFTR trafficking and Cl- channel function. Am J Physiol Lung Cell Mol Physiol 281:L71-L78.
52. Widdicombe JH, Ueki IF, Emery D, Margolskee D, Yergey J, Nadel JA. 1989. Release of cyclooxygenase products from primary cultures of tracheal epithelia of dog and human. Am J Physiol 257:L361-L365.
53. Wu YZ, Abolhassani M, Ollero M, Dif F, Uozumi N, Lagranderie M, Shimizu T, Chignard M, Touqui L. 2010. Cytosolic phospholipase A2alpha mediates Pseudomonas aeruginosa LPS-induced airway constriction of CFTR -/- mice 1. Respir Res 11:49.
54. Zaman MM, Gelrud A, Junaidi O, Regan MM, Warny M, Shea JC, Kelly C, O'Sullivan BP, Freedman SD. 2004. Interleukin 8 secretion from monocytes of subjects heterozygous for the deltaF508 cystic fibrosis transmembrane conductance regulator gene mutation is altered. Clin Diagn Lab Immunol 11:819-824.